235 related articles for article (PubMed ID: 14770041)
21. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
Chatterjee S; Premachandran S; Shukla J; Poduval TB
J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
[TBL] [Abstract][Full Text] [Related]
22. Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of streptozotocin-diabetic rat lung.
Ozansoy G; Güven C; Ceylan A; Can B; Aktan F; Oz E; Gönül B
Cell Biochem Funct; 2005; 23(6):421-6. PubMed ID: 15540254
[TBL] [Abstract][Full Text] [Related]
23. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin mediates the pressor effect of hypertonic saline solution in endotoxic shock.
Giusti-Paiva A; Martinez MR; Bispo-da-Silva LB; Salgado MC; Elias LL; Antunes-Rodrigues J
Shock; 2007 Apr; 27(4):416-21. PubMed ID: 17414425
[TBL] [Abstract][Full Text] [Related]
25. Enhanced acetylcholine-induced dilation in afferent arterioles in simvastatin-fed rats.
Inman SR; Caprio TW; Drummond E; Mueller M; Entenman K
Vascul Pharmacol; 2006 Jan; 44(1):17-21. PubMed ID: 16290053
[TBL] [Abstract][Full Text] [Related]
26. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
Rydgren T; Sandler S
Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
[TBL] [Abstract][Full Text] [Related]
27. Effect of simvastatin on proinflammatory cytokines production during lipopolysaccharide-induced inflammation in rats.
Nezić L; Skrbić R; Dobrić S; Stojiljković MP; Satara SS; Milovanović ZA; Stojaković N
Gen Physiol Biophys; 2009; 28 Spec No():119-26. PubMed ID: 19893089
[TBL] [Abstract][Full Text] [Related]
28. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
[TBL] [Abstract][Full Text] [Related]
29. Role of dexamethasone on vasopressin release during endotoxemic shock.
Batalhão ME; Moreto V; Stabile AM; Antunes-Rodrigues J; Carnio EC
Regul Pept; 2008 Apr; 147(1-3):67-71. PubMed ID: 18243366
[TBL] [Abstract][Full Text] [Related]
30. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
31. Effects of post-treatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats.
Hsu BG; Yang FL; Lee RP; Peng TC; Chen HI
Clin Exp Pharmacol Physiol; 2005; 32(1-2):24-9. PubMed ID: 15730430
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin attenuates lipopolysaccharide-induced airway mucus hypersecretion in rats.
Ou XM; Wang BD; Wen FQ; Feng YL; Huang XY; Xiao J
Chin Med J (Engl); 2008 Sep; 121(17):1680-7. PubMed ID: 19024099
[TBL] [Abstract][Full Text] [Related]
33. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
[TBL] [Abstract][Full Text] [Related]
35. Effect of simvastatin therapy on blood and tissue ATP levels and erythrocyte membrane lipid composition.
Calişkan S; Calişkan M; Kuralay F; Onvural B
Res Exp Med (Berl); 2000 Feb; 199(4):189-94. PubMed ID: 10743676
[TBL] [Abstract][Full Text] [Related]
36. N-acetylcysteine abrogates acute lung injury induced by endotoxin.
Kao SJ; Wang D; Lin HI; Chen HI
Clin Exp Pharmacol Physiol; 2006; 33(1-2):33-40. PubMed ID: 16445696
[TBL] [Abstract][Full Text] [Related]
37. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
[TBL] [Abstract][Full Text] [Related]
38. A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock.
Cuzzocrea S; Mazzon E; Di Paola R; Esposito E; Macarthur H; Matuschak GM; Salvemini D
J Pharmacol Exp Ther; 2006 Oct; 319(1):73-81. PubMed ID: 16815867
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of early treatment with lipoic acid in LPS-induced lung injury in rats.
Goraca A; Józefowicz-Okonkwo G
J Physiol Pharmacol; 2007 Sep; 58(3):541-9. PubMed ID: 17928649
[TBL] [Abstract][Full Text] [Related]
40. The role of nitric oxide and protein kinase C in lipopolysaccharidemediated vascular hyporeactivity.
Karimi G; Fatehi Z; Gholamnejad Z
J Pharm Pharm Sci; 2006; 9(1):119-23. PubMed ID: 16849013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]